TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
144 hedge funds and large institutions have $558M invested in Tvardi Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
+18
Holders Change %
+14.29%
% of All Funds
3.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
33
Increased
49
Reduced
35
Closed
15
Calls
$8.31M
Puts
$10.8M
Net Calls
-$2.48M
Net Calls Change
-$1.72M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.6M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$21.9M |
| 3 |
BlackRock
New York
|
+$12.5M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.27M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$8.04M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$16.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.5M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.88M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$5.08M |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$4.42M |
